MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NeoGenomics Company Profile (NASDAQ:NEO)

Consensus Ratings for NeoGenomics (NASDAQ:NEO) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.80 (21.89% upside)

Analysts' Ratings History for NeoGenomics (NASDAQ:NEO)
Show:
DateFirmActionRatingPrice TargetActions
5/11/2016Roth CapitalInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Benchmark Co.Boost Price TargetBuy$8.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016BTIG ResearchReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Janney Montgomery ScottInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Craig HallumBoost Price TargetBuy$8.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for NeoGenomics (NASDAQ:NEO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/21/2016        
4/27/2016Q116($0.07)$0.03$57.00 million$59.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2016Q415$0.02($0.03)$26.46 million$27.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115($0.02)($0.01)$23.36 million$23.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414$0.01$0.02$24.30 million$25.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.01)($0.01)$22.43 million$23.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2014Q214$0.01$0.01$19.84 million$20.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2014Q413$0.02$0.04$17.80 million$18.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313$0.01$0.02$16.84 million$16.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.01$16.20 million$15.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for NeoGenomics (NASDAQ:NEO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.01)($0.01)($0.01)
Q2 20161$0.01$0.01$0.01
Q3 20161$0.04$0.04$0.04
Q4 20161$0.05$0.05$0.05
(Data provided by Zacks Investment Research)
Dividend History for NeoGenomics (NASDAQ:NEO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for NeoGenomics (NASDAQ:NEO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/27/2016Oort Douglas M VanCEOSell481,387$8.73$4,202,508.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Steven A RossInsiderSell18,000$8.50$153,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Steven A RossInsiderSell15,000$8.22$123,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Steven C JonesVPSell177,745$8.21$1,459,286.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Steven A RossInsiderSell112,500$8.11$912,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016George CardozaCFOSell32,000$6.83$218,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016Oort Douglas M VanCEOSell450,000$7.10$3,195,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2016Alison L HannahDirectorBuy10,000$6.90$69,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Lynn A TetraultDirectorBuy3,500$7.72$27,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Robert J ShovlinCOOBuy6,550$7.75$50,762.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Steven C JonesVPSell385,000$8.09$3,114,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Bruce K CrowtherDirectorBuy6,400$7.81$49,984.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2014Robert H HorelVPSell32,389$4.21$136,357.69View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Robert H HorelVPSell62,893$4.20$264,150.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Michael T DentDirectorSell11,800$4.50$53,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014George CardozaCFOSell60,000$4.28$256,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2014Michael T DentDirectorSell33,200$4.51$149,732.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Robert P GaspariniInsiderSell100,000$3.49$349,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Robert GaspariniInsiderSell10,000$3.65$36,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2014Maher AlbitarInsiderBuy14,492$3.51$50,866.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014Michael T DentDirectorSell300,000$3.00$900,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2013Robert P GaspariniInsiderSell20,100$3.70$74,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013George CardozaCFOSell20,000$3.66$73,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2013Robert P GaspariniInsiderSell32,996$3.67$121,095.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Robert P GaspariniInsiderSell32,146$3.67$117,975.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2013Steven C JonesVPSell112,969$3.58$404,429.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2013Steven C JonesDirectorSell100,000$3.71$371,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for NeoGenomics (NASDAQ:NEO)
DateHeadline
06/29/16 05:17 PMEquity Research and Technical Review on NeoGenomics, Inc. (NASDAQ:NEO) - Press Telegraph
06/27/16 07:38 AMNeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : June 27, 2016 -
06/25/16 04:58 PMNeoGenomics, Inc. (NASDAQ:NEO) Earnings Glance and Target Price Review - Engelwood Daily
06/25/16 04:58 PMWhat's Propelling NeoGenomics, Inc. to Decline So Much? - Engelwood Daily
06/23/16 08:07 AMNeogenomics Inc. (NasdaqCM:NEO) Stock Momentum Hits Strength - CML News
06/20/16 01:55 PMETF’s with exposure to NeoGenomics, Inc. : June 20, 2016 -
06/20/16 07:03 AMCompany Shares of NeoGenomics Drops by -5.12% - Trade Calls
06/16/16 09:38 AMRecently Issued Stock Ratings For NeoGenomics, Inc. (NEO) - Fiscal Standard
06/16/16 08:14 AMBet on These 5 Stocks with Upgraded Broker Ratings -
06/15/16 08:54 AMNeogenomics (NEO) Sees Hammer Chart Pattern: Time to Buy? -
06/15/16 07:29 AMNeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : June 15, 2016 -
06/13/16 08:20 AMTraders Spotlight: Novartis AG (NYSE:NVS) , NeoGenomics, Inc. (NASDAQ:NEO) - Street Updates
06/09/16 12:28 PMETF’s with exposure to NeoGenomics, Inc. : June 9, 2016 -
06/08/16 05:49 PMForm 8-K NEOGENOMICS INC For: Jun 07 - StreetInsider.com
06/08/16 11:12 AMNEOGENOMICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial Stat -
06/08/16 09:12 AMNeoGenomics, Inc. :NEO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 -
06/08/16 08:21 AMNEOGENOMICS INC. (NASDAQ:NEO) Financial Condition Compared to S&P 500 - CML News
06/05/16 08:05 AMGlobal Cancer/Tumor Profiling Market Propelled by Shift Towards Point-of-Care Diagnostics
06/04/16 08:12 AMNeogenomics Incorporated (NASDAQ:NEO) Shorted Shares Decreased By 9.23% - HNN
06/03/16 05:51 PMStock Review and Earnings Check on NeoGenomics, Inc. (NASDAQ:NEO) - HNN
05/31/16 05:39 PMNASDAQ Highs: Take-Two Interactive Software Inc. (NASDAQ:TTWO), Neogenomics Inc. (NASDAQ:NEO), Weibo ... - KC Register - NASDAQ Highs: Take-Two Interactive Software Inc. (NASDAQ:TTWO), Neogenomics Inc. (NASDAQ:NEO), Weibo ...KC RegisterOn Friday Take-Two Interactive Software Inc. (NASDAQ:TTWO) share price closed at $38.80. Company net profit margin stands at -0.60% whereas its return on equity (ROE) is -1.50%. Take-Two Interactive Software Inc. (NASDAQ:TTWO) is -6.79% away from ...and more »
05/31/16 09:24 AMAnalyst Opinions on: NeoGenomics, (NEO), Anacor Pharmaceuticals (ANAC) - Beacon Chronicle - Analyst Opinions on: NeoGenomics, (NEO), Anacor Pharmaceuticals (ANAC)Beacon ChronicleNeoGenomics, Inc. (NASDAQ:NEO) currently has High Price Target of $11.00. The Low and Mean Price Targets are $7.75. and $9.68 respectively. These price targets are a consensus analysis of 7 brokers. When having a look at Recommendation Trends of ...and more »
05/31/16 09:24 AMNeoGenomics, Inc. (NASDAQ:NEO) Quarterly EPS From Continuing Operations Stands At $0.002 - Stocks Daily - NeoGenomics, Inc. (NASDAQ:NEO) Quarterly EPS From Continuing Operations Stands At $0.002Stocks DailyFor the year ended 2016-03-31 NeoGenomics, Inc. (NASDAQ:NEO) basic consolidated EPS reported was $-0.0419. For the quarter ended 2016-03-31, it came at $-0.0419. EPS is a part of a firm's earnings that is owed to each outstanding stock. Calculated ...
05/31/16 09:24 AMPortfolio Of Healthcare Movers: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , NeoGenomics, Inc. (NASDAQ:NEO) - Is stories - Portfolio Of Healthcare Movers: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , NeoGenomics, Inc. (NASDAQ:NEO)Is storiesSarepta Therapeutics, Inc. (NASDAQ:SRPT) decreased -4.55% to $21.19 while traded 6.6 million shares on 5/27/2016. The stock price negotiated for value between $20.82 to $23.04 in recent trading session. During the past 52 weeks, the stock's price ...
05/31/16 09:24 AMNext Weeks Broker Price Targets For NeoGenomics, Inc. (NEO) - Share Trading News - Next Weeks Broker Price Targets For NeoGenomics, Inc. (NEO)Share Trading News05/11/2016 – Roth Capital began new coverage on NeoGenomics, Inc. giving the company a “buy” rating. They now have a USD 10 price target on the stock. 04/28/2016 – NeoGenomics, Inc. had its “buy” rating reiterated by analysts at Benchmark. They now ...and more »
05/31/16 09:24 AMInsider Trading in Focus: NeoGenomics, Inc. (NASDAQ:NEO) - The Point Review - Insider Trading in Focus: NeoGenomics, Inc. (NASDAQ:NEO)The Point ReviewNeoGenomics, Inc. (NASDAQ:NEO) insiders have most recently took part in a trading activity. On 5/18/2016 Ross Steven A, CIO sold 18,000 shares having total worth of $153,000 at the price of $8.50 per share, following the transaction a total of 4,500 ...
05/28/16 09:39 AMNeoGenomics, Inc.'s Stock Is Buy After Today's Huge Increase - HNN - NeoGenomics, Inc.'s Stock Is Buy After Today's Huge IncreaseHNNThe stock of NeoGenomics, Inc. (NASDAQ:NEO) is a huge mover today! The stock increased 3.75% or $0.32 during the last trading session, hitting $8.99. About 1.04 million shares traded hands or 109.22% up from the average. NeoGenomics, Inc.Analyst Coverage: NeoGenomics, Inc. (NEO)Risers & Fallersall 3 news articles »
05/27/16 10:45 AMEarnings Review and Stock Rundown for NeoGenomics, Inc. (NASDAQ:NEO) - Wall Street Hints and News - Earnings Review and Stock Rundown for NeoGenomics, Inc. (NASDAQ:NEO)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting NeoGenomics, Inc. (NASDAQ:NEO) to post ...and more »
05/26/16 07:42 AMEarnings Estimates Moving Higher for Neogenomics (NEO): Time to Buy? -
05/26/16 05:22 AMNeoGenomics, Inc. (NASDAQ:NEO) EPS Estimate At $0.02 - RealistInvestor.com - NeoGenomics, Inc. (NASDAQ:NEO) EPS Estimate At $0.02RealistInvestor.comThe EPS projection of NeoGenomics, Inc. (NASDAQ:NEO) for quarter ended 2016-09-30 is $0.02. A week earlier, the EPS target was $0.02 against target of $0.02, a month earlier. This target stood at $0.02 60 days ago against estimate of $0.02 90 days ...
05/26/16 05:22 AMNotable Moving Stocks: NeoGenomics, Inc. (NASDAQ:NEO) , GW Pharmaceuticals Plc (NASDAQ:GWPH) - Street Updates - Notable Moving Stocks: NeoGenomics, Inc. (NASDAQ:NEO) , GW Pharmaceuticals Plc (NASDAQ:GWPH)Street UpdatesOn 5/25/2016, shares of NeoGenomics, Inc. (NASDAQ:NEO) fell -2.48% in trading session and finally closed at $8.65. The company most recent volume stood at 751.56 thousand shares as compared to its average volume of 403.74 thousand shares. Over the ...and more »
05/24/16 02:07 PMHold Calls Count For NeoGenomics, Inc. (NASDAQ:NEO) At 1 - Investor Newswire - Hold Calls Count For NeoGenomics, Inc. (NASDAQ:NEO) At 1Investor NewswireBuy calls count on NeoGenomics, Inc. (NASDAQ:NEO)'s stock stands at 0 while Sell recommendations is 0. Hold recommendation is 1. NeoGenomics, Inc. (NASDAQ:NEO) has a total of 5 Strong Buy recommendations and 0 Strong Sell advises as of ...and more »
05/24/16 07:22 AMIntegra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty -
05/21/16 01:26 PMShare Recap and Earnings Focus on NeoGenomics, Inc. (NASDAQ:NEO) - Wall Street Hints and News - Share Recap and Earnings Focus on NeoGenomics, Inc. (NASDAQ:NEO)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating NeoGenomics, Inc.and more »
05/21/16 01:26 PMIs NeoGenomics, Inc. (NASDAQ:NEO) Stock a Sell after Steven Ross's Insider Trading? - Wall Street Hints and News - Is NeoGenomics, Inc. (NASDAQ:NEO) Stock a Sell after Steven Ross's Insider Trading?Wall Street Hints and NewsThe CIO of Neogenomics Inc, Steven Ross is in the stock market news today. It was reported in a public form filled by Steven Ross and submitted to the DC-based SEC on May 20, 2016, he unloaded 18,000 shares from the Florida-based Neogenomics Inc ...Neogenomics Inc (NEO) Files Form 4 Insider Selling : Steven A Ross Sells 18000 SharesMarket DigestRoth Capital Assumes NeoGenomics to BuyTrade Callsall 4 news articles »
05/21/16 01:26 PMForm 4 NEOGENOMICS INC For: May 18 Filed by: ROSS STEVEN A - StreetInsider.com - Form 4 NEOGENOMICS INC For: May 18 Filed by: ROSS STEVEN AStreetInsider.comGet daily under-the-radar research with StreetInsider.com's Stealth Growth Insider. Get your Free Trial here. FORM 4, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549. STATEMENT OF CHANGES IN BENEFICIAL ...and more »
05/21/16 08:40 AMForm 4 NEOGENOMICS INC For: May 18 Filed by: ROSS STEVEN A - 1. On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. 2. On April 22, 2013, Mr. Ross was granted 150,000 options to purchase common stock of the Company.
05/20/16 01:51 PMNeogenomics Incorporated (NASDAQ:NEO) Short Interest Increased By 6.65% - Wall Street Hints and News - Neogenomics Incorporated (NASDAQ:NEO) Short Interest Increased By 6.65%Wall Street Hints and NewsNeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The company has a market cap of $655.49 million. The Firm operates in Laboratory Testing Segment. It currently has negative earnings. The Company's Laboratory ...
05/19/16 01:26 PMHave a look at Price Moves: NeoGenomics, Inc. (NASDAQ:NEO) , BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Street Updates - Have a look at Price Moves: NeoGenomics, Inc. (NASDAQ:NEO) , BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)Street UpdatesOn 5/18/2016, shares of NeoGenomics, Inc. (NASDAQ:NEO) rose +0.35% in trading session and finally closed at $8.52. The company most recent volume stood at 468.06 thousand shares as compared to its average volume of 371.57 thousand shares.
05/14/16 08:26 AMInvestors Checklist Stocks: NeoGenomics, Inc. (NASDAQ:NEO) , Curis, Inc. (NASDAQ:CRIS) - Street Updates - Investors Checklist Stocks: NeoGenomics, Inc. (NASDAQ:NEO) , Curis, Inc. (NASDAQ:CRIS)Street UpdatesOn 5/12/2016, NeoGenomics, Inc. (NASDAQ:NEO) ended trading session lower at $8.37 with -1.65%. The company traded a volume of 314.21 thousand shares as comparison to average volume of 354.29 thousand shares. During the 52 –week period, the ...and more »
05/13/16 08:08 AMNeoGenomics, Inc. (NEO) Updated Broker Price Targets - Share Trading News - NeoGenomics, Inc. (NEO) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of NeoGenomics, Inc. (NEO). The latest reports which are currently in issue on Friday 13th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
05/13/16 08:08 AMWhat Is NeoGenomics, Inc. (NASDAQ: NEO) Up To? - Scibility Media - Scibility MediaWhat Is NeoGenomics, Inc. (NASDAQ: NEO) Up To?Scibility MediaIn the recent Form 10-Q filing, the management of NeoGenomics, Inc. (NASDAQ: NEO) outlined how the company was gearing up for future growth and also called to memory what has worked for the company in the past. NeoGenomics posted record revenue ...NeoGenomics, Inc. (NEO) Research Coverage Started at Roth CapitalWashington News WireNeoGenomics, Inc. (NEO) Now Covered by Analysts at Roth CapitalWeb Breaking NewsInsider Selling: NeoGenomics, Inc. (NEO) Insider Sells 15000 Shares of StockNewsWay 21Franklin Independent -The Post -Equities Focusall 13 news articles »
05/12/16 08:04 AMPerformance Recap and Target Perspective on NeoGenomics, Inc. (NASDAQ:NEO) - B.O.D.Y Confidential - Performance Recap and Target Perspective on NeoGenomics, Inc. (NASDAQ:NEO)B.O.D.Y ConfidentialSome investors may pay more attention to short short-term share performance, while others may be more interested in stock action over a longer period of time. In the latest trading session, shares of NeoGenomics, Inc. (NASDAQ:NEO) moved +0.48%. In ...and more »
05/11/16 07:24 AMNeoGenomics, Inc. (NEO) Research Coverage Started at Roth Capital - Washington News Wire - Washington News WireNeoGenomics, Inc. (NEO) Research Coverage Started at Roth CapitalWashington News WireNeoGenomics logo Equities researchers at Roth Capital assumed coverage on shares of NeoGenomics, Inc. (NASDAQ:NEO) in a research note issued on Wednesday, StockTargetPrices.com reports. The brokerage set a “buy” rating and a $10.00 price target ...NeoGenomics, Inc. (NEO) Now Covered by Analysts at Roth CapitalWeb Breaking NewsNeoGenomics, Inc. (NEO) Insider Steven A. Ross Sells 15000 Shares of StockNewsWay 21Neogenomics Inc (NEO) Files Form 4 Insider Selling : Steven A Ross Sells 15000 SharesMarket Digestall 8 news articles »
05/10/16 05:10 PMNEOGENOMICS INC Files SEC form 10-Q, Quarterly Report -
05/09/16 07:42 AMNeoGenomics, Inc. (NEO) Broker Price Targets For The Coming Week - Share Trading News - NeoGenomics, Inc. (NEO) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of NeoGenomics, Inc. (NEO). The latest reports which are currently in issue on Sunday 8th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
05/07/16 07:27 AMEarnings Outlook on NeoGenomics, Inc. (NASDAQ:NEO) - B.O.D.Y Confidential - Earnings Outlook on NeoGenomics, Inc. (NASDAQ:NEO)B.O.D.Y ConfidentialAnalysts and investors will be anticipating NeoGenomics, Inc. (NASDAQ:NEO)'s next earnings release which is expected to be posted on or around 2016-07-28. Sell-side research firms on Wall Street are expecting that the company will post EPS of $-0.08 ...and more »
04/28/16 05:09 AMNEOGENOMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
04/11/16 07:20 AMNeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016 - [at noodls] - FT. MYERS, Fla., April 11, 2016 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its first quarter 2016 financial results on Wednesday April 27, 2016. ... This is ...
04/07/16 07:39 PMETF’s with exposure to NeoGenomics, Inc. : April 8, 2016 -
About NeoGenomics

NeoGenomics logoNeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company offers testing services, which includes Cytogenetics testing, which is the study of normal and abnormal chromosomes and their relationship to disease; fluorescence in-situ hybridization (FISH) testing, which is a branch of cancer genetics that focuses on detecting and locating the presence or absence of specific deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which is a way to measure the characteristics of cell populations; immunohistochemistry (IHC) testing, which is a process of identifying cell proteins in a tissue section utilizing the principle of antibodies binding specifically to in biological tissues., and molecular testing, which is a cancer diagnostic tool focusing on the analysis of DNA and ribonucleic acid (RNA), as well as the structure and function of genes at a molecular level.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NEO
  • CUSIP:
Key Metrics:
  • Previous Close: $8.04
  • 50 Day Moving Average: $8.49
  • 200 Day Moving Average: $7.38
  • P/E Ratio: N/A
  • P/E Growth: 3.33
  • Market Cap: $620.02M
  • Current Quarter EPS Consensus Estimate: $0.12 EPS
Additional Links:
NeoGenomics (NASDAQ:NEO) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha